Bovie Medical Corporation Announces Five Year Contract to Sell Bovie Products within the U.S. Government’s Healthcare System

MELVILLE, N.Y.--(BUSINESS WIRE)--Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced it has been awarded a contract by the General Services Administration (GSA). Bovie’s Federal Supply Schedule (FSS) was awarded by the Office of Acquisition and Materiel Management’s National Acquisition Center (NAC), located in Hines, Illinois. The NAC is the largest combined contracting entity within the Department of Veterans Affairs (VA) and is responsible for supporting the health care requirements of the VA as well as the needs of other Government agencies. The initial contract period is for five years.

Under the terms of the contract, Bovie Medical Corporation products are available for sale throughout the entire federal healthcare continuum, the single largest healthcare provider in the United States, which includes 1,606 Veterans Healthcare facilities, Department of Defense medical treatment facilities, Health & Human Services (HHS) and other government agencies. The annual medical equipment/supply budget for these agencies is estimated to total in excess of $5 billion annually.

Rob Saron, chief sales and marketing officer and a director of Bovie Medical, stated, “Securing the FSS contract has taken over two years and a lot of hard work negotiating with the U.S. government. Our marketing team is excited about the potential sales opportunities afforded by this agreement.”

For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie’s website www.boviemed.com.

Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.

Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission. For forward-looking statements in this new release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.

Contact:

Investor: Buttonwood Advisory Group, Inc. John Aneralla, 800-940-9087

MORE ON THIS TOPIC